Summary.-Arginase activity was found to be increased in precancerous nodules and mammary tumour when compared with the mammary gland. Proline inhibited the mammary tumour arginase and up to 30 mmol concentration the inhibition follows first order kinetics. Hill analysis of the inhibition of arginase by proline showed that proline inhibits the arginase activity by competing directly at the active site without conformational change. The inhibition may be of regulatory importance, involving a feedback mechanism in mammary tumours.
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SYNTHESIS of proline from arginine has been reported in bacteria] and animal systems (Costilow and Laycock, 1971; Peisach and Strecker, 1962; Strecker, 1965; Eliasson and Strecker, 1966; Hill and Chambers, 1967; Reddy and Campbell, 1.969; Kaysen and Strecker, 1973) . In mammary gland a major conversion of labelled arginine into proline occurs, without formation of labelled citrulline Linzell, 1966, 1967) . It has also been reported that in the mammary gland, during lactation, the arginase activity does not function as part of the urea cycle (Folley and Greenbaum, 1947; Greengard, Sahib and Knox, 1970; Yip and Knox, 1972) . This suggests that the urea cycle is inoperative in mammary gland and that arginine can be diverted through the reactions of arginase, ornithine aminotransferase and A1-pyrroline 5-carboxylate reductase to the synthesis of proline, and proline is the end product of the metabolic conversion of arginine. In the present study, we were interested in investigating the effects of glutamic acid and proline on arginase activity in mouse mammary tumours. The model was chosen because mouse mammary tumours of several strains are known to contain high arginase activity (Bach and Lasnitzki, 1947; Bhide, 1971) .
MATERIALS AND METHODS
Preparation of tissue extracts.-Seven-to 9-month old mice of ICRC strain (Ranadive et al., 1961) bearing spontaneous mammary tumours were used for experimental purposes. Mammary glands from normal and tumour bearing mice of ICRC strain were also used. Mice were killed by cervical dislocation and mammary gland (normal and tumour bearing) and the tumours were dissected out and chilled in an ice bath. After washing in cold Tyrode's balanced salt solution and blotting on the filter paper, the tissue was weighed and homogenized in the cold 0-025 mol/l sodium glycinate (pH 9 5) to make a 10% (w/v) Kinetic parameters.-The slopes, Vm, and Michaelis constants (Km) were calculated by the method of least squares. The inhibitor constants (Ki) were calculated by the method of Dixon and Webb (1964) Campbell (1966) .
RESULTS

Aryinase activity
All the enzyme assays were carried out under conditions which measured initial velocities. Table I shows the arginase activity in mammary glands from normal and tumour bearing mice and in mammary tumour. The enzyme activity was found to be greater in the mammary glands of tumour bearing animals and in the mammary tumour when compared with the normal mammary gland (Table I) .
Similar increase of arginase activity associated with cellular proliferation and mammary tumours has been reported earlier (Smith and Richterich, 1957; Bach and Lasnitzki, 1947; Bach and SimonReuss, 1953; Bhide, 1971) .
Proline inhibition
Of the 3 amino acids studied at 40 mmol concentration on the mammary tumour arginase, proline showed 28% inhibition of arginase activity (Table II) . Hydroxyproline showed 10% inhibition whereas glutamic acid had an insignificant effect on arginase activity (Table II) . Proline showed 23% inhibition of arginase activity with acetone dried powders (Table  II) .
The effect of proline was studied at different concentrations of arginine (Fig.  1) . The plots were linear up to 30 mmol proline at 3 arginine concentrations studied Kinetics of proline inhibition The kinetics of inhibition of arginase by proline is shown in the form of the Lineweaver-Burk double reciprocal plot and as well as the Dixon plot (Fig. 2a, b) . The inhibition of arginase by proline shows peculiar kinetics. Although a competitive inhibition on the whole, this amino acid gave non-linear reciprocal plots tending towards non-competitive inhibition at lower substrate concentrations (Fig. 2a) . The experiment was repeated with acetone dried powders to check the possibility of interference by the small ions and free amino acids present in the homogenate on the inhibition of arginase activity by proline. The mode of inhibition was found to be same with acetone powders, indicating that interference due to small molecules is unlikely. The Dixon plot (Fig. 2b ) also showed a tendency towards a mixed type of inhibition (Dixon and Webb, 1964 (Kesava Rao, Reddy and Swami, 1973) . The Km was found to be 6 14 mmol for mammary tumour arginase (Table III ). An increase in Km and a decrease in Vm was observed in the presence of proline, thus indicating the competitive inhibition (Table III) . The average Ki value was found to be 26-1 mmol for proline (Table  III) . The Km values reported by different workers for liver arginase from different species vary from 2 mmol to 40 mmol (Mora et al., 1965; Campbell, 1966; Hirsch-Kolb et al., 1970; Schimke, 1964) . The Km value for ox brain arginase is 9 mmol (Gasiorowska, Porembska and Mochnacha, 1969) .
The non-linear kinetics with respect to arginine concentration probably suggest the presence of co-operative interactions. The data in Fig. 2a were replotted according to the Hill eqtuationi (Fig. 3) which gave a straight line with Hill coefficient (n) of 1D0 for the arginase, both in the presence and absence of proline. A Hill coefficient greater than one indicates positive co-operativity, less than one negative co-operativity and equal to one non-interacting sites (Koshland, 1970) . The present study therefore indicates that proline inhibits the arginase activity by competing directly at the active site without conformational change (Koshland, 1970) . The plot of (Vo -v)/v versus concentration of proline (Fig. 4) also showed a tendency towards straight lines with slope values (n) 1D0 at 3 arginine concentrations studied, thus confirming that proline competes with arginine for the catalytic site of arginase with no apparent gross co-operativity. The inhibition of arginase by proline is of particular interest. Arginine, which is the substrate for arginase, is a branched chain amino acid containing 6 carbon atoms, whereas proline is a heterocyclic amino acid. Thus apparently there is no structural relationship between arginine and proline but proline shows competitive inhibition of arginase. Mammalian liver homogenates can convert proline to ornithine by the enzymes proline oxidase and ornithine aminotransferase (Smith, Benziman and Strecker, 1967) . Ornithine is an inhibitor of arginase (Kesava Rao, Reddy and Swami, 1973) . However, it is doubtful whether this pathway is operative in mammarytumour and evenif it is operative it is unlikely that enough ornithine would be formed from the proline added to the arginase assay system in the absence of co-factors for these enzymes to cause the observed inhibition of arginase. It has been reported that proline inhibits purified arginase from liver and kidney (Hunter and Downs, 1945; Kaysen and Strecker, 1973) and as well as arginase activity in sheep liver homogenate (Kesava Rao, Reddy and Swami, 1973) . Thus, the inhibition of arginase by proline is not due to the ornithine that might have formed from the added proline but by proline itself. The arginase in mammary gland during lactation does not function as part of the urea cycle, because the cycle is incomplete (Folley and Greenbaum, 1947; Yip and Knox, 1972) , and arginine can be converted to proline involving the enzymes arginase, ornithine aminotransferase and Al-pyrroline 5-carboxylate reductase (Yip and Knox, 1972) . Proline formation from arginine has been reported in bacterial and animal systems (Costilow and Laycock, 1971; Peisach and Strecker, 1962; Strecker, 1965; Eliasson and Strecker, 1966; Hill and Chambers, 1967; Reddy and Campbell, 1969; Kaysen and Strecker, 1973) . Arginase has a quarternary structure (Hirch-Kolb and Greenberg, 1968; Sorof and Kish, 1969; Carvajal et al. ,1971; Vielle-Breitburd and Orth, 1972) and shows sigmoid saturation curves as a function of arginine concentration under certain conditions (Cabello, 1967) which are the two properties shown by most enzymes susceptible for " end product " inhibition. It is tempting to speculate that the inhibition of arginase by proline may be of regulatory importance, involving a feedback mechanism in mammary tumours. Further work on this line may prove worthwhile.
